Article
BRCA1 mutation, leptin and estrogen levels in breast cancer patients.
European journal of gynaecological oncology - 1 Jan 2005
Rzepka-Górska I, Tarnowski B, Chudecka-Glaz A, Górski B
Abstract excerpt
Pre- and postmenopausal patients with breast cancer were screened for mutation of the BRCAI gene and estrogens and leptin levels were measured. In postmenopausal BRCA1 mutation carriers, leptin levels were significantly lower and correlated with the body mass index (BMI). No significant difference in leptin levels was revealed between pre- and postmenopausal patients. Our findings suggest the existence of an...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.